LABU:ARCA-Direxion Daily S&P Biotech Bull 3X Shares

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 55.13

Change

+0.20 (+0.36)%

Market Cap

USD 0.28B

Volume

3.44M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.05%

Management Expense Ratio: 1.14 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-25 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B.. 1.10 %

-2.15 (-5.80%)

USD 10.94B
QLD ProShares Ultra QQQ 0.95 %

-0.98 (-1.22%)

USD 5.97B
SSO ProShares Ultra S&P500 0.90 %

-0.33 (-0.47%)

USD 4.66B
FNGU MicroSectors FANG+ Index 3X Le.. 0.00 %

-7.19 (-2.42%)

USD 4.21B
SPXL Direxion Daily S&P500® Bull 3.. 1.00 %

-0.82 (-0.70%)

USD 4.15B
TECL Direxion Daily Technology Bull.. 1.17 %

-2.44 (-3.54%)

USD 3.23B
UPRO ProShares UltraPro S&P500 0.92 %

-0.48 (-0.78%)

USD 2.95B
FAS Direxion Daily Financial Bull .. 1.04 %

+0.93 (+1.00%)

USD 2.45B
TNA Direxion Daily Small Cap Bull .. 1.10 %

-0.20 (-0.61%)

USD 2.23B
YINN Direxion Daily FTSE China Bull.. 1.02 %

+0.91 (+5.08%)

USD 0.96B

ETFs Containing LABU

ULTY Tidal Trust II 5.23 % 0.00 %

-0.26 (-1.73%)

USD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 67.77% 100% F 99% N/A
Dividend Return 0.33% 67% D+ 18% F
Total Return 68.11% 100% F 99% N/A
Trailing 12 Months  
Capital Gain -33.18% 14% F 8% B-
Dividend Return 0.39% 28% F 4% F
Total Return -32.79% 14% F 7% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 20.28% 77% C+ 92% A
Dividend Return 20.37% 76% C+ 91% A-
Total Return 0.09% 16% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 63.44% 16% F 4% F
Risk Adjusted Return 32.11% 51% F 45% F
Market Capitalization 0.28B 90% A- 52% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.